Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).
- DOI
- 10.1634/theoncologist.2010-0257
- Published
- 2010
- Container
- The oncologist
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1634/theoncologist.2010-0257,
title = {Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).},
author = {Cohen MH and Johnson JR and Chattopadhyay S and Tang S and Justice R and Sridhara R and Pazdur R},
year = {2010},
journal = {The oncologist},
doi = {10.1634/theoncologist.2010-0257},
url = {https://doi.org/10.1634/theoncologist.2010-0257}
}RIS
TY - JOUR TI - Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC). AU - Cohen MH AU - Johnson JR AU - Chattopadhyay S AU - Tang S AU - Justice R AU - Sridhara R AU - Pazdur R PY - 2010 JO - The oncologist DO - 10.1634/theoncologist.2010-0257 UR - https://doi.org/10.1634/theoncologist.2010-0257 ER -
APA
MH, C., JR, J., S, C., S, T., R, J., R, S., & R, P. (2010). Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).. The oncologist. https://doi.org/10.1634/theoncologist.2010-0257
Source records
- pubmed · retrieved 2026-09-26T21:01:54.541Z